The Burkholderia cenocepacia K56-2 pleiotropic regulator Pbr, is required for stress resistance and virulence

Microbial Pathogenesis

Volumn 48, Issue 5, 2010, Pages 168-177

  Ramos, Christian G ^a   Sousa, Silvia A ^a   Grilo, André M ^a   Eberl, Leo ^b   Leitão, Jorge H ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Burkholderia cenocepacia K56 2 virulence; Caenorhabditis elegans infection model; Pbr pleiotropic regulatory protein; Phenazine synthesis; Stress resistance

Indexed keywords

AMINO ACID; PHENAZINE; PHENAZINE BIOSYNTHESIS REGULATOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BIOSYNTHESIS; BURKHOLDERIA CENOCEPACIA; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA CONTENT; GENE INSERTION; NEMATODIASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC STRESS; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; STRESS;

ANIMALS; BACTERIAL PROTEINS; BIOFILMS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CAENORHABDITIS ELEGANS; CYSTIC FIBROSIS; GENES, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; OSMOLAR CONCENTRATION; PHENAZINES; PLASMIDS; PROMOTER REGIONS, GENETIC; STRESS, PHYSIOLOGICAL; TRANSCRIPTION, GENETIC; VIRULENCE; VIRULENCE FACTORS;

BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; CAENORHABDITIS ELEGANS;

EID: 77952954310     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.02.006     Document Type: Article

References (46)

1. Vanlaere E., Baldwin A., Gevers D., Henry D., De Brandt E., LiPuma J.J., et al. a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 2009, 59:102-111.
2. Vanlaere E., LiPuma J.J., Baldwin A., Henry D., De Brandt E., Mahenthiralingam E., et al. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol 2008, 58:1580-1590.
3. Mahenthiralingam E., Urban T.A., Goldberg J.B. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Micro 2005, 3:144-156.
4. Govan J.R., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996, 60:539-574.
5. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984, 104:206-210.
6. Courtney J.M., Dunbar K.E.A., McDowell A., Moore J.E., Warke T.J., Stevenson M., et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004, 3:93-98.
7. Manno G., Dalmastri C., Tabacchioni S., Vandamme P., Lorini R., Minicucci L., et al. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian cystic fibrosis center. J Clin Microbiol 2004, 42:1491-1497.
8. Leitão J.H., Sousa S.A., Cunha M.V., Salgado M.J., Melo-Cristino J., Barreto M.C., et al. Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center. Eur J Clin Microbiol Infect Dis 2008, 27:1101-1111.
9. Biddick R., Spilker T., Martin A., LiPuma J.J. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett 2003, 228:57-62.
10. Law R.J., Hamlin J.N.R., Sivro A., McCorrister S.J., Cardama G.A., Cardona S.T., et al. Functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model. J Bacteriol 2008, 190:7209-7218.
11. Flannagan R.S., Aubert D., Kooi C., Sokol P.A., Valvano M.A. Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo. Infect Immun 2007, 75:1679-1689.
12. Maloney K.E., Valvano M.A. The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun 2006, 74:5477-5486.
13. Saldias M.S., Lamothe J., Wu R., Valvano M.A. Burkholderia cenocepacia requires the rpoN sigma factor for biofilm formation and intracellular trafficking within macrophages. Infect Immun 2008, 76:1059-1067.
14. Mavrodi D.V., Blankenfeldt W., Thomashow L.S. Phenazine compounds in fluorescent Pseudomonas spp.: Biosynthesis and regulation. Ann Rev Phytopathol 2006, 44:471-485.
15. Delaney S.M., Mavrodi D.V., Bonsall R.F., Thomashow L.S. phzO, a Gene for biosynthesis of 2-Hydroxylated phenazine compounds in Pseudomonas aureofaciens 30-84. J Bacteriol 2001, 183:318-327.
16. Darling P., Chan M., Cox A.D., Sokol P.A. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun 1998, 66:874-877.
17. Dennis J.J., Zylstra G.J. Plasposons: modular self-cloning minitransposon derivatives for rapid genetic analysis of Gram-negative bacterial genomes. Appl Environ Microbiol 1998, 64:2710-2715.
18. Moreira L.M., Videira P.A., Sousa S.A., Leitão J.H., Cunha M.V., Sá-Correia I. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem Biophys Res Commun 2003, 312:323-333.
19. Cardona S.T., Wopperer J., Eberl L., Valvano M.A. Diverse pathogenicity of Burkholderia cepacia complex strains in the Caenorhabditis elegans host model. FEMS Microbiol Lett 2005, 250:97-104.
20. Sambrook J., MacCallum P., Russell D. Molecular cloning: a laboratory manual 2001, ColdSpring Harbour Laboratory Press.
21. Holden M.T.G., Seth-Smith H.M.B., Crossman L.C., Sebaihia M., Bentley S.D., Cerdeno-Tarraga A.M., et al. The Genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 2009, 191:261-277.
22. Rutherford K., Parkhill J., Crook J., Horsnell T., Rice P., Rajandream M.-A., et al. Artemis: sequence visualization and annotation. Bioinformatics 2000, 16:944-945.
23. Parsons J.F., Calabrese K., Eisenstein E., Ladner J.E. Structure and mechanism of Pseudomonas aeruginosa PhzD, an isochorismatase from the phenazine biosynthetic pathway. Biochemistry 2003, 42:5684-5693.
24. Blankenfeldt W., Kuzin A.P., Skarina T., Korniyenko Y., Tong L., Bayer P., et al. Structure and function of the phenazine biosynthetic protein PhzF from Pseudomonas fluorescens. Proc Natl Acad Sci USA 2004, 101:16431-16436.
25. Sessitsch A., Coenye T., Sturz A.V., Vandamme P., Barka E.A., Salles J.F., et al. Burkholderia phytofirmans sp. nov., a novel plant-associated bacterium with plant-beneficial properties. Int J Syst Evol Microbiol 2005, 55:1187-1192.
26. 54-dependent genes in Escherichia coli. Microbiol Mol Biol Rev 2001, 65:422-444.
27. Neilands J.B. Siderophores: structure and function of microbial iron transport compounds. J Biol Chem 1995, 270. 26,723-6.
28. Sokol P.A., Darling P., Woods D.E., Mahenthiralingam E., Kooi C. Role of Ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding l-ornithine N5-oxygenase. Infect Immun 1999, 67:4443-4455.
29. Danhorn T., Fuqua C. Biofilm formation by plant-associated bacteria. Ann Rev Microbiol 2007, 61:401-422.
30. Richau J.A., Leitão J.H., Correia M., Lito L., Salgado M.J., Barreto C., et al. Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center. J Clin Microbiol 2000, 38:1651-1655.
31. Maddula V., Zhang Z., Pierson E., Pierson L. Quorum sensing and phenazines are involved in biofilm formation by Pseudomonas chlororaphis (aureofaciens) strain 30-84. Microb Ecol 2006, 52:289-301.
32. Maddula V.S.R.K., Pierson E.A., Pierson L.S. Altering the ratio of phenazines in Pseudomonas chlororaphis (aureofaciens) strain 30-84: effects on biofilm formation and pathogen inhibition. J. Bacteriol 2008, 190:2759-2766.
33. Sousa S.A., Ramos C.G., Almeida F., Meirinhos-Soares L., Wopperer J., Schwager S., et al. Burkholderia cenocepacia J2315 acyl carrier protein: a potential target for antimicrobials development?. Microb Pathog 2008, 45:331-336.
34. Mahajan-Miklos S., Tan M.-W., Rahme L.G., Ausubel F.M. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 1999, 96:47-56.
35. Lefebre M.D., Valvano M.A. Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates. Appl Environ Microbiol 2002, 68:5956-5964.
36. Sousa S.A., Moreira L.M., Wopperer J., Eberl L., Sá-Correia I., Leitão J.H. The Burkholderia cepacia bceA gene encodes a protein with phosphomannose isomerase and GDP-D-mannose pyrophosphorylase activities. Biochem Biophys Res Comm 2007, 353:200-206.
37. Schuster M., Urbanowski M.L., Greenberg E.P. Promoter specificity in Pseudomonas aeruginosa quorum sensing revealed by DNA binding of purified LasR. Proc Natl Acad Sci USA 2004, 101. 15,833-9.
38. Bradford M.M. A rapid and sensitive method for the quatification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
39. O'Toole G.A., Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998, 28:449-461.
40. Smeal B.C., Bender L., Jungkind D.L., Hastie A.T. Simultaneous production of rhamnolipids, 2-alkyl-4-hydroxyquinolines, and phenazines by clinical isolates of Pseudomonas aeruginosa. J Clin. Microbiol 1987, 25:1308-1310.
41. Hernandez M.E., Kappler A., Newman D.K. Phenazines and other redox-active antibiotics promote microbial mineral reduction. Appl Environ Microbiol 2004, 70:921-928.
42. Sousa S.A., Ramos C.G., Moreira L.M., Leitão J.H. The hfq gene is required for stress resistance and full virulence of Burkholderia cepacia to the nematode Caenorhabditis elegans. Microbiology 2010, 156:896-908.
43. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
44. Moy T.I., Ball A.R., Anklesaria Z., Casadei G., Lewis K., Ausubel F.M. Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci USA 2006, 103:10414-10419.
45. Markowitz V.M., Korzeniewski F., Palaniappan K., Szeto E., Werner G., Padki A., et al. The integrated microbial genomes (IMG) system. Nucl Acids Res 2006, 34:D344-D348.
46. Lau G.W., Ran H., Kong F., Hasset D.J., Mavrodi D. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 2004, 72:4275-4278.